Investors and diligence
Investor and M&A IP Diligence
Investors and acquirers need to know whether the IP story is real, owned, defensible, and commercially relevant. V24 turns filings, ownership, risk, and opportunity into clear decision material.
Priorities
What the IP strategy needs to cover
V24 connects technical protection with commercial timing, investor expectations, and competitor movement.
Ownership, assignment, disclosure, and filing-risk review points
Portfolio strength, gap, and opportunity assessment
Post-investment IP roadmap and prosecution priorities
Relevant packages
Start with the right route
Most sector matters begin with a focused sprint, an investor pack, competitive intelligence, or a global filing roadmap.
First filing
First Patent Sprint
Fundraising
Investor IP Pack
Market strategy
Competitive IP Intelligence
International growth
Global Filing Roadmap
Related Knowledge Hub
Practical IP thinking for this sector
Selected articles that connect sector strategy with filings, diligence, launch planning, and portfolio decisions.
Turning IP Diligence Into a Growth Signal
How founders can use IP diligence to show operational maturity, not just survive investor questions about filings, ownership, risks, and freedom to operate.
Building an IP Portfolio Investors Understand
A story-led guide to turning patents, trade marks, designs, know-how, and ownership records into an IP narrative investors can actually diligence.
The Art of Selling IP
Why selling IP is nothing like selling a simple product: value depends on commercial relevance, durability, ownership, and serious due diligence.
Related sectors
Other V24 expertise
Innovation portfolios often cross technical boundaries.
AI and software
AI and Software IP
Patent, trade mark, data, and portfolio strategy for AI, SaaS, machine learning, automation, and software-enabled companies.
View sector expertiseHardware and deep tech
Hardware, Electronics and Semiconductors
IP strategy for hardware, electronics, semiconductors, devices, sensors, embedded systems, and manufacturing innovation.
View sector expertiseMedTech and life sciences
MedTech and Life Sciences IP
Patent and portfolio strategy for medical technology, diagnostics, devices, biotech-enabled platforms, and health innovation.
View sector expertiseNext step
Discuss your sector IP priorities
Talk to V24 about the filings, risks, competitors, and commercial milestones that matter most.